3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow difelikefalin: new trials by email Literature Review of difelikefalin trials Research Report on difelikefalin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis Difelikefalin Injection - End Stage Renal Disease on Hemodialysis | Phase 1 | Completed | Vifor Fresenius Medical Care Renal Pharma | 30 | 2023-06-26 | 2025-02-14 |
| CR845-100303: Study to Assess the Potential of Physical Withdrawal From Intravenous CR845 (Difelikefalin) in Hemodialysis Patients CR845 0.5 mcg/kg, Placebo - Hemodialysis | Phase 1 | Completed | Cara Therapeutics, Inc. | 35 | 2019-12-31 | 2022-09-08 |
| Study to Investigate the Effects of Single Intravenous Doses of Difelikefalin (CR845) on the QTc Interval in Healthy Subjects CR845 0.5 mcg/kg IV, CR845 3 mcg/kg IV, Moxifloxacin 400 mg Oral Tablet - Healthy | Phase 1 | Completed | Cara Therapeutics, Inc. | 57 | 2019-06-20 | 2020-02-21 |
Kidney Failure, Chronic (1) · Renal Insufficiency, Chronic (1)
Cara Therapeutics, Inc. (2) · Vifor Fresenius Medical Care Renal Pharma (1)
United States (2) · China (1)